Carbocisteine or Hypertonic Saline for Acute Respiratory Failure

B Bronwen Connolly N Naomi Dickson (Northern Ireland Clinical Trials Unit, Belfast, United Kingdom) C Christina Campbell (Northern Ireland Clinical Trials Unit, Belfast, United Kingdom) J Judy M. Bradley B Brenda O’Neill A Ashley Agus (Northern Ireland Clinical Trials Unit, Belfast, United Kingdom) M Mike Barker (Pharmacy Department, Guys and St. Thomas’ NHS Foundation Trust, London) J Jeremy S. Bewley (Intensive Care, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom) B Bronagh Blackwood (Wellcome–Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, United Kingdom) M Mark Borthwick (Pharmacy Department, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom) L Luigi Camporota (Critical Care, Guy’s and St. Thomas’ NHS Foundation Trust, London) M Marc Chikhani (Critical Care and Anaesthesia, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom) M Mike Clarke P Paul Dark (Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Manchester, United Kingdom) L Lisa Higgins (Critical Care Unit, University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom) P Penelope Lambert (Intensive Care, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom) T Thomas Lunn (Intensive Care, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom) C Cliona McDowell (Northern Ireland Clinical Trials Unit, Belfast, United Kingdom) M Margaret McFarland (Pharmacy Department, Belfast Health and Social Care Trust, Belfast, United Kingdom) U Una McShane (Northern Ireland Clinical Trials Unit, Belfast, United Kingdom) R Reena Mehta (School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King’s College London, London) B Ben Messer (Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom) B Ben Morton N Nehal Patel (Critical Care Unit, University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom) G Gavin D. Perkins (Warwick Medical School, University of Warwick, Coventry, United Kingdom) D Deborah Rowley (Critical Care Unit, University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom) M Murali Shyamsundar (Department of Critical Care, Belfast Health and Social Care Trust, Belfast, United Kingdom) J Jonathan A. Silversides (Wellcome–Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, United Kingdom) G Gordon Sturmey (Independent patient partner, United Kingdom) J John Warburton B Barry Williams (Independent patient partner, United Kingdom) R Ranjit Lall (Warwick Clinical Trials Unit, University of Warwick, Warwick, United Kingdom) D Daniel F. McAuley (Wellcome–Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, United Kingdom)

Article Details

Volume / Issue Vol. 1, Issue 1
Published June 10, 2026
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (33)

B

Bronwen Connolly

N

Naomi Dickson

Northern Ireland Clinical Trials Unit, Belfast, United Kingdom

C

Christina Campbell

Northern Ireland Clinical Trials Unit, Belfast, United Kingdom

J

Judy M. Bradley

B

Brenda O’Neill

A

Ashley Agus

Northern Ireland Clinical Trials Unit, Belfast, United Kingdom

M

Mike Barker

Pharmacy Department, Guys and St. Thomas’ NHS Foundation Trust, London

J

Jeremy S. Bewley

Intensive Care, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom

B

Bronagh Blackwood

Wellcome–Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, United Kingdom

M

Mark Borthwick

Pharmacy Department, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

L

Luigi Camporota

Critical Care, Guy’s and St. Thomas’ NHS Foundation Trust, London

M

Marc Chikhani

Critical Care and Anaesthesia, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

M

Mike Clarke

P

Paul Dark

Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Manchester, United Kingdom

L

Lisa Higgins

Critical Care Unit, University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom

P

Penelope Lambert

Intensive Care, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom

T

Thomas Lunn

Intensive Care, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom

C

Cliona McDowell

Northern Ireland Clinical Trials Unit, Belfast, United Kingdom

M

Margaret McFarland

Pharmacy Department, Belfast Health and Social Care Trust, Belfast, United Kingdom

U

Una McShane

Northern Ireland Clinical Trials Unit, Belfast, United Kingdom

R

Reena Mehta

School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King’s College London, London

B

Ben Messer

Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom

B

Ben Morton

N

Nehal Patel

Critical Care Unit, University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom

G

Gavin D. Perkins

Warwick Medical School, University of Warwick, Coventry, United Kingdom

D

Deborah Rowley

Critical Care Unit, University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom

M

Murali Shyamsundar

Department of Critical Care, Belfast Health and Social Care Trust, Belfast, United Kingdom

J

Jonathan A. Silversides

Wellcome–Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, United Kingdom

G

Gordon Sturmey

Independent patient partner, United Kingdom

J

John Warburton

B

Barry Williams

Independent patient partner, United Kingdom

R

Ranjit Lall

Warwick Clinical Trials Unit, University of Warwick, Warwick, United Kingdom

D

Daniel F. McAuley

Wellcome–Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, United Kingdom